The latest call
FetchingDyadic International, Inc. reported on 2026年11月13日. We are fetching the call transcript; its summary follows once the transcript is in.
US$0.33-6.6%11月13日 收盘
数据截至2026年9月30日,来自2026年11月13日提交的10-Q
Just reported
From Dyadic International, Inc.'s results release of 2026年11月13日; its quarterly report has since been filed.
Actual
US$449.1K
-61% y/y
-53% q/q
Guided
—
No guide given
Actual
-US$0.04
Guided
—
No guide given
Actual
-US$1.8M
| 指标 | 截至该日的 3 个月2026年9月30日 | 截至该日的 3 个月2025年9月30日 | 变动 |
|---|---|---|---|
| 营业收入合计 | US$449.1K | US$1.2M | -61.44% |
| 利润 | -US$1.4M | -US$2M | +31.32% |
| 每股收益 | -US$0.04 | -US$0.06 | +33.33% |
这些是单季度数字,不是滚动一年——本站其他地方的数字覆盖十二个月,会大得多。季节性业务在两者之间摆动很大:ServiceNow 在十二月季度赚 20 亿美元自由现金流,在六月季度只有 5 亿。
对比对象是去年同一季度,而不是分析师预测。要说“超预期”或“不及预期”需要一致预期数据,那是我们没有的授权数据——而搞错它比不提更糟。
Dyadic International, Inc. reported on 2026年11月13日. We are fetching the call transcript; its summary follows once the transcript is in.
“During the third quarter, we reached a key commercialization milestone for our animal-free protein portfolio, advancing market adoption through initial product sales and growing customer engagement across the food, life sciences, and biopharmaceutical sectors,”
逐字引自公告,且只在文件将其归于具名人士时才展示。
Dyadic Applied BioSolutions is a global biotechnology company that uses its proprietary microbial platforms to produce recombinant proteins that are sold or licensed to partners across the life sciences, food and nutrition, and bio-industrial markets. These high-quality proteins are designed to enable customers to develop more efficient, scalable, and sustainable products. Dyadic’s Dapibus™ and C1 expression systems support flexible, cost-effective manufacturing, and are the foundation of a growing portfolio of commercial and partnered programs.
公司自己的描述,取自公告末尾。
引述和公司简介来自 Dyadic International, Inc. 于 2026年11月13日 提交的第 2.02 项 8-K 文件;表格根据其季度报告编制。 在 EDGAR 上阅读公告 股价已按拆股和分红复权。
Guided
—
No guide given
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.